Search

everythinglearnresearchcommunity

for

Search:↓

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Lack of KSR1 stops certain skin tumors in mice.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

AMPK activation may reduce melanoma risk in red-haired individuals.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

BMS-470539 reduces skin fibrosis and inflammation.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Tacrolimus helps mice grow hair by activating hair follicles.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.